FDA grants Sandoz approval for Ziextenzo in oncology care

6th November 2019 Uncategorised 0

The drug has been approved and marketed in Europe as Ziextenzo since 2018.

More: FDA grants Sandoz approval for Ziextenzo in oncology care
Source: News